Philips announces European availability of innovations to advance personalized and effective cardiac care at EuroPCR 2021
Amsterdam, Netherlands – May 18 – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in healthcare technology, today announced the European availability of new innovations in its unique portfolio of solutions that integrate imaging, devices, software, IT and services at every point of a heart. patient journey to EuroPCR 2021 (May 18-20). During the virtual event, Philips showcases its latest innovations in image-guided therapy that advance procedures, including percutaneous coronary interventions (PCI) to treat narrowing of the coronary arteries.
“At Philips, we envision personalized, effective and clinically intelligent cardiac care that generates optimal results throughout the patient journey,” said Bert van Meurs, Head of Image Guided Therapy Business at Philips. “At this year’s Virtual EuroPCR, we are showcasing how we bring together devices, systems, software and services that improve cardiac care by building clinical confidence, increasing efficiency throughout the care journey. and improving the experience for patients and staff. ”
Philips Response Application Platform – IntraSight Mobile
Philips’ new interventional application platform – IntraSight Mobile – brings together imaging and physiology applications on a mobile system for the treatment of coronary and peripheral diseases. . IntraSight Mobile builds on the success of IntraSight, integrating intravascular diagnostic applications into a smart, simple and transparent workflow solution for intervention laboratories.
The IntraSight platform enables interventional cardiologists to perform intravascular ultrasound (IVUS) imaging and physiological measurements of fractional flow reserve (FFR) and instantaneous wave ratio (iFR) to accurately identify the location of lesions causing ischemia. IntraSight Mobile is based on the same software as IntraSight and is compatible with Philips’ current and future portfolio of IVUS and physiological consumables. It includes a touchscreen PC panel and a rugged multi-modality touchscreen module mounted on a modern, easy-to-maneuver cart. Its intuitive user interface and streamlined workflow provide clinicians with an exceptional user experience while optimizing laboratory performance.
Philips OmniWire Pressure Guidewire European Launch
Philips OmniWire Pressure Guidewire, the world’s first solid-core pressurewire for coronary artery procedures, has been CE marked and is now available in Europe . With its revolutionary solid core construction, physicians can more easily maneuver the wire through the patient’s circulatory system to measure blood pressure along the vessel and guide the placement of catheters and stents. OmniWire supports iFR and FFR measurements, which can be co-recorded on angiograms to precisely identify parts of a vessel that require treatment.
Presentation of the Philips laser system
The new Philips laser system offers plug-and-play simplicity for coronary and peripheral atherectomy procedures. Philips laser system compatible catheters are indicated in more vessel types than any other atherectomy device, and it is the only laser atherectomy technology proven for intra-stent restenosis (ISR) in the vascular system. coronary and peripheral. [3,4]. Additionally, the system is also the only laser system available for lead extraction procedures (removal of leads from the pacemaker or defibrillator around the heart). Smaller, lighter and more manageable, the system boots up in 30 seconds and features an intuitive touchscreen interface with guided workflow prompts that minimize the need for technician training.
The recently introduced Philips Interventional Hemodynamic System with IntelliVue X3 patient monitor is also showcased at EuroPCR, which provides advanced hemodynamic (blood flow) measurements at the cath lab table and continuous monitoring of key vital signs throughout the journey. of the patient. In addition, Philips Cardiovascular Imaging and Information Manager – IntelliSpace Cardiovascular – supports informed decision making by providing a comprehensive overview of the patient’s cardiovascular care continuum and saves time and unnecessary labor and dramatically improves efficiency. and the work flow.
As the demand for cardiology services continues to increase, clinicians and administrators are balancing the delivery of high quality care and optimal outcomes with the pressure to increase efficiency and care for more patients. Definitive diagnoses, innovative procedures and personalized patient management are essential to meet these demands. Philips offers a unique portfolio of solutions centered on its next generation image guided therapy system – Azurion. Individually, the company’s innovations help solve some of cardiology’s most important daily challenges, and together they connect across the care journey to create a powerful ecosystem that helps realize the vision to provide better care. heart with greater efficiency. For more information, visit www.philips.com/cardiology.
 The Philips mobile response application platform – IntraSight Mobile – is CE marked for sale in Europe and has received FDA 510 (k) clearance for sale in the United States.
 Philips Pressure Guide Wire – OmniWire – is CE marked for sale in Europe and has received FDA 510 (k) clearance for sale in the United States.
 The Philips laser system is CE marked for sale in Europe. The system is not currently available for sale in the United States.
 ISR suitable for ELCA (P002208) and Turbo-Power (P015612)
For more information, please contact:
Philips Global Press Office
Email: [email protected]philips.com
Fabienne van der Feer
Philips Image Guided Therapy
Phone: + 31 622 698 001
Email: [email protected]
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading healthcare technology company focused on improving the health and well-being of people, and enabling better outcomes across the continuum health – from healthy living and prevention to diagnosis, treatment and home care. Philips harnesses cutting-edge technology and in-depth clinical and consumer knowledge to deliver integrated solutions. Based in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and healthcare informatics, as well as consumer healthcare and home care. Philips reported 2020 sales of € 17.3 billion and employs around 77,000 people with sales and service in more than 100 countries. Information about Philips is available at www.philips.com/newscenter.